Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

SAMWOP creates space for sharing research
2016-12-06

Description: SAMWOP Tags: SAMWOP 

Dr Kristina Riedel, Head of the UFS Department of
Linguistics and Language Practice; middle:
Prof Nancy Kula, of the University of Essex; back:
from left, Dr Elias Malete, lecturer at the UFS
Department of Linguistics and Language Practice,
Prof Andy Chebanne, from the University of Botswana;
and Lesoetsa Motsamai, from the University of Stellenbosch,
at the SAMWOP workshop on 24 November 2016.
Photo: Rulanzen Martin

“The Southern African Microlinguistics Workshop (SAMWOP) creates space for sharing the latest research, networking and building stronger collaboration amongst linguists.”

This is what Dr Kristina Riedel, Head of the Department of Linguistics and Language Practice at the University of the Free State (UFS), said of the 5th SAMWOP hosted by her department. The workshop, hosted from 24 to 26 November 2016, also provided linguists who work on theory and language description in South Africa, the opportunity to network. “As a free conference it is very important, particularly for students and junior scholars.”

International delegates attend workshop

Participants at the workshop were from eight countries including the US, Botswana, Mozambique, Brazil and the UK. Prof Nancy Kula (University of Essex, UK), who was recently appointed as research associate to the department, presented jointly with Xiaoxi Liu, work on depressor effects (consonants which lower tones) in Bantu languages. Other presenters discussed Bantu languages, Khoisan languages and Afrikaans.

Microlinguistics analyses language and sound

“Microlinguistics focuses on analysing language data that deals with language sounds, structures and meaning, rather than language in society,” Dr Riedel said. “The range and diversity of the research on African languages presented at SAMWOP5 were a true highlight. There is a need for more research into African languages and SAMWOP presents the opportunity to scholars in the field to share their work, including in the accredited open-access proceedings.

“We are happy that we were able to hold a very successful and well-attended workshop despite the disruptions to the academic calendar this year,” the professor said.

The Linguistics Society of Southern Africa supported the cause in the form of a grant with additional support from the Office of Dean of Humanities at the UFS.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept